To ensure competitiveness in global bio-enterprise, the Department
of Science and Technology (DOST) and Department of Agriculture
(DA) are institutionalizing biotech research and development
funding.
This is envisioned to secure the Philippines' niche in the
global bio-enterprise with focus on the budget allocation
for biotech products research and development particularly
in the area of biopharming or the commercialization of plant-made
pharmaceuticals.
DOST Secretary Estrella Alabastro said they have identified
biotechnology as one of five key priority areas where research
and development funds will be spent by the agency in the
next four years.
Earlier, President Arroyo had declared the first week of
July as National Biotechnology Week to promote safe and responsible
use of modern biotechnology and its products as one of the
several means to achieve and sustain food security, equitable
access to health services, sustainable and safe environment,
and industry development.
In the DOST's R&D Agenda for 2006-2010, biotechnology
projects have been classified into food, industrial, environmental,
medicine and health, agricultural and forest, marine and
aquatic biotechnology.
Alabastro said it also has well-trained scientists and technologists
in the field, and has diverse flora and fauna, which excellent
resources for biological processes.
"Biotechnology has been tagged as the sunrise industry
of the millennium. In the knowledge-based global economy,
cutting edge biotechnology provides the innovations that
add value, bringing forth new products and services, and
creating new products and services, and creating new markets
and business."
For his part, Agriculture Undersecretary Segfredo Serrano
said the DA is institutionalizing funding for biotech R&D
and has identified biopharming as one of their targets.
He said substantial amount will be poured to advance biopharming,
particularly to develop a supply market for natural ingredients
and bio-fortified crops or products that have medical benefits
in the world market.